期刊文献+

血清中脑钠肽与蒽环类药物累积量的相关性研究 被引量:1

The relationship of brain natriuretic peptide and accumulated dose of anthracycline
暂未订购
导出
摘要 目的:探讨血清中脑钠肽(BNP)与蒽环类药物累积量的相关性。方法:收集使用蒽环类药物化疗后的淋巴瘤患者30例,统计患者所用蒽环类药物的累积量,检测患者血清中的BNP值,分析血清中BNP与蒽环类药物累积量的相关性。结果:蒽环类药物累积量为0~950mg,血清中BNP为5~1276pg/ml,蒽环类药物累积量与血清中BNP无线性相关(P>0.05)。结论:不能推荐使用血清中BNP来检测蒽环类药物心脏毒性累积的严重程度。 Objective:To investigate the serum brain natriuretic peptide(BNP) and the accumulation of anthracyclines relevance.Methods:Use of anthracycline chemotherapy for lymphoma,30 patients,statistics were used anthracycline cumulative amount of test serum BNP values of serum BNP and the accumulation of anthracycline correlation.Results:The accumulation of anthracyclines was 0 to 950 mg,serum BNP was 5 to 1 276 pg/ml,accumulation of anthracyclines and the linear correlation of serum BNP(P0.05).Conclusion:Serum BNP can not be recommended to detect drugs anthracene ring the severity of the cumulative cardiac toxicity.
出处 《中国当代医药》 2010年第34期32-32,34,共2页 China Modern Medicine
关键词 脑钠肽 蒽环类药物 心力衰竭 充血性 Brain natriuretic peptide Anthracycline Heart failure Congestive
  • 相关文献

参考文献6

  • 1覃玉桃,钟进才.阿霉素心肌病及其检测[J].临床荟萃,2000,15(24):1138-1139. 被引量:13
  • 2Doust JA,Pietrzak E,Dobson A,et al.How well does B-type natriuretic peptide predict death and cardiac events in patients with heart failure:systematic review[J].BMJ,2005,330(19):625-624.
  • 3Mehmet Kantar,Erturk Levent,Nazan Cetingni MD,et al.Plasma natriuretic peptides levels and echocardiographic findings in late subclinical Anthracycline toxicity[J].Pediatric Hematology and Oncology,2008,25(12):723-733.
  • 4Toru Suzuki,Doubun Hayashi,Tsutomu Yamazaki MD,et al.Elevated Btype natriuretic peptide levels after anthracycline administration[J].American Heart Journal,1998,136(8):362-365.
  • 5Bedirhan Erkus,Selda Demirtas,Aysegul Akbay Yarpuzluet,al.Early prediction of anthracycline induced cardiotoxicity[J].Acta Padiatrica,2006,96(10):506-509.
  • 6Pinarli FG,Oguz A,Tunaoglu lS,et al.Late cardiac evaluation of children with solid tumors after anthracycline chemotherapy[J].Pediatr Blood Cancer,2005,44(6):370-377.

二级参考文献5

共引文献12

同被引文献11

  • 1周新华,张岩,滕士阶,仲崇明,王怡练,孙黎明,左逸夫.血浆cTnI水平对化疗药心肌毒性的诊断意义[J].放射免疫学杂志,2007,20(2):164-166. 被引量:3
  • 2彭玉娜,谭获,王颖超,区碧如,张还珠,黄振倩.阿霉素导致兔血清肌钙蛋白T变化的实验研究[J].国际医药卫生导报,2007,13(16):13-15. 被引量:4
  • 3Barrett-Lee PJ, Dion JM, Farrell C, et al. Expert oponion on the use of anthracyclines in patients with advanced breast cancer at car- diac risk [J]. Anna Onco, 2009,20(5) :816-827.
  • 4Horacek JM, Ticby M, JEbavy L, et al. Use of multiple biomarkers for evaluation of anthracycline-induced cardiotoxicity in patients with acute myeloid leukemia[J]. Exp Oncol, 2008,30(2) :157-159.
  • 5Germanakis I, Anagnostatou N, Kalmanti M. Troponins and natriuretic peptides in the monitoring of anthracycline cardiotoxicity [J]. Pediatr Blood Cancer, 2008,51(3) :327-333.
  • 6Sterba M, Sim unek T, Popelova 0, et al. Early detection of anthracycline cardiotoxicity in a rabbit model: left ventricle filling pattern versus troponin T determination [J]. Physiol Res, 2007, 56 (5) :535-545.
  • 7Kilickap S, Barista I, Akgul E, et al. cTnT can be a useful marker for early detection of anthracycline cardiotoxicity [J] . Ann Oncol, 2005,16(5) :798-804.
  • 8Polena S, Shikara M, Naik s, et al. Troponin I as a marker of doxorubicin induced cardiotoxicity [J]. Proc West Pharmacol Soc, 2005,48:142-144.
  • 9Nousiainen T, Jantunen E, Vanninen E, et al. Natriuretic peptides as markers of cardiotoxicity during doxorubicin treatment for non- Hodgkins lymphoma [J]. Eur J Haematol,l999 ,62(2) :135-141.
  • 10郭海霞,陈纯,薛红漫,符少萍,覃丽君,周敦华,黄科,方建培.白血病儿童化疗中严重心脏损害的临床分析[J].中国实用医药,2008,3(20):5-7. 被引量:4

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部